• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症:磁共振成像中的钆增强

Multiple sclerosis: gadolinium enhancement in MR imaging.

作者信息

Grossman R I, Gonzalez-Scarano F, Atlas S W, Galetta S, Silberberg D H

出版信息

Radiology. 1986 Dec;161(3):721-5. doi: 10.1148/radiology.161.3.3786722.

DOI:10.1148/radiology.161.3.3786722
PMID:3786722
Abstract

Magnetic resonance (MR) images--both nonenhanced and enhanced with gadolinium DTPA/dimeglumine (Gd)--were compared with high-iodine (88.1 g I) computed tomographic (HICT) scans in demonstrating lesions in 15 patients known to have multiple sclerosis (MS). T1-weighted, mixed (T1, proton density, and T2), and T2-weighted MR pulse sequences were used. More than 20 lesions in each of 14 patients were demonstrated by pre-Gd mixed images and T2WI. Nine patients had clinical symptoms of active disease. Gd-enhanced T1WI showed at least one lesion that appeared to correspond with newly reported symptoms or signs. In addition, three clinically stable patients showed enhancement. Enhancement was best seen on 3-minute T1WI. HICT scans showed enhancement in four of the nine patients with active disease and in none of five clinically stable patients. Gd-enhanced MR imaging appears to be more sensitive than HICT in the detection of the transient abnormalities of the blood-brain barrier that occur in patients with active MS and appears capable of distinguishing active lesions that may correspond to the anatomic regions responsible for abnormal clinical findings.

摘要

在15例已知患有多发性硬化症(MS)的患者中,对磁共振(MR)图像(包括未增强的和用钆喷酸葡胺/葡甲胺(Gd)增强的)与高碘(88.1 g碘)计算机断层扫描(HICT)进行了比较,以显示病变情况。使用了T1加权、混合(T1、质子密度和T2)以及T2加权的MR脉冲序列。14例患者中,Gd增强前的混合图像和T2WI均显示出20多个病变。9例患者有疾病活动的临床症状。Gd增强的T1WI显示至少一个病变似乎与新出现的症状或体征相对应。此外,3例临床稳定的患者也有强化表现。在3分钟的T1WI上强化表现最为明显。HICT扫描显示,9例疾病活动患者中有4例出现强化,而5例临床稳定患者均未出现强化。Gd增强的MR成像在检测活动性MS患者血脑屏障的短暂异常方面似乎比HICT更敏感,并且似乎能够区分可能与导致异常临床发现的解剖区域相对应的活动性病变。

相似文献

1
Multiple sclerosis: gadolinium enhancement in MR imaging.多发性硬化症:磁共振成像中的钆增强
Radiology. 1986 Dec;161(3):721-5. doi: 10.1148/radiology.161.3.3786722.
2
Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging.多发性硬化症疾病活动与钆增强磁共振成像相关。
Ann Neurol. 1987 Mar;21(3):300-6. doi: 10.1002/ana.410210312.
3
Multiple sclerosis: serial study of gadolinium-enhanced MR imaging.多发性硬化症:钆增强磁共振成像的系列研究。
Radiology. 1988 Oct;169(1):117-22. doi: 10.1148/radiology.169.1.3420246.
4
Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity.复发缓解型多发性硬化:在确定疾病活动度方面,序列增强磁共振成像与临床发现的比较
AJR Am J Roentgenol. 1992 Nov;159(5):1041-7. doi: 10.2214/ajr.159.5.1414773.
5
Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis.钆-DTPA磁共振成像增强在多发性硬化症中的系列研究
Neurology. 1990 Apr;40(4):591-5. doi: 10.1212/wnl.40.4.591.
6
Gd-DTPA in clinical MR of the brain: 1. Intraaxial lesions.钆喷酸葡胺在脑部临床磁共振成像中的应用:1. 脑内病变
AJR Am J Roentgenol. 1986 Dec;147(6):1223-30. doi: 10.2214/ajr.147.6.1223.
7
Gd-DTPA-enhanced MR imaging of the brain in patients with meningitis: comparison with CT.脑膜炎患者脑部的钆喷酸葡胺增强磁共振成像:与CT的比较
AJR Am J Roentgenol. 1990 Apr;154(4):809-16. doi: 10.2214/ajr.154.4.2107681.
8
[Brain magnetic resonance with magnetization transfer in multiple sclerosis. Lesion hyperintensity before and after intravenous gadolinium administration].[多发性硬化症中采用磁化传递的脑磁共振成像。静脉注射钆对比剂前后的病变高信号]
Radiol Med. 1999 Sep;98(3):138-43.
9
[Clinical usefulness of MRI in acute phase of spinal multiple sclerosis--influence of high-dose steroid therapy in acute phase].[MRI在脊髓型多发性硬化急性期的临床应用——急性期大剂量类固醇治疗的影响]
Rinsho Shinkeigaku. 1995 Mar;35(3):225-30.
10
Multicenter double-blind placebo-controlled study of gadopentetate dimeglumine as an MR contrast agent: evaluation in patients with cerebral lesions.钆喷酸葡胺作为磁共振造影剂的多中心双盲安慰剂对照研究:对脑损伤患者的评估
AJR Am J Roentgenol. 1989 Apr;152(4):813-23. doi: 10.2214/ajr.152.4.813.

引用本文的文献

1
Restoring brain barriers: an innovative approach for treating neurological disorders.恢复脑屏障:一种治疗神经系统疾病的创新方法。
Fluids Barriers CNS. 2025 Jul 10;22(1):72. doi: 10.1186/s12987-025-00688-z.
2
Conventional and Advanced Magnetic Resonance Imaging Biomarkers of Multiple Sclerosis in the Brain.大脑中多发性硬化症的传统和先进磁共振成像生物标志物
Cureus. 2025 Mar 2;17(3):e79914. doi: 10.7759/cureus.79914. eCollection 2025 Mar.
3
Investigation of the Relationship Between Heavy Metals (Cadmium, Arsenic, and Lead) and Metallothionein in Multiple Sclerosis.
多发性硬化症中重金属(镉、砷和铅)与金属硫蛋白之间关系的研究
Cureus. 2024 Aug 13;16(8):e66754. doi: 10.7759/cureus.66754. eCollection 2024 Aug.
4
Neurodegeneration in multiple sclerosis.多发性硬化中的神经退行性变。
WIREs Mech Dis. 2023 Jan;15(1):e1583. doi: 10.1002/wsbm.1583. Epub 2022 Aug 10.
5
Inhibition of astrocytic DRD2 suppresses CNS inflammation in an animal model of multiple sclerosis.星形胶质细胞 DRD2 抑制作用可抑制多发性硬化症动物模型中的中枢神经系统炎症。
J Exp Med. 2022 Sep 5;219(9). doi: 10.1084/jem.20210998. Epub 2022 Jul 25.
6
Harmonizing Magnetic Resonance Imaging Protocols for Veterans With Multiple Sclerosis.统一针对患有多发性硬化症退伍军人的磁共振成像方案。
Fed Pract. 2022 Apr;39(Suppl 1):S10-S13. doi: 10.12788/fp.0251. Epub 2022 Apr 12.
7
Potential Biomarkers Associated with Multiple Sclerosis Pathology.与多发性硬化症病理学相关的潜在生物标志物。
Int J Mol Sci. 2021 Sep 25;22(19):10323. doi: 10.3390/ijms221910323.
8
Extended perfusion protocol for MS lesion quantification.用于多发性硬化症病变定量的延长灌注方案。
Open Med (Wars). 2020 Jun 8;15(1):520-530. doi: 10.1515/med-2020-0100. eCollection 2020.
9
Imaging in Pediatric Multiple Sclerosis : An Iconographic Review.儿童多发性硬化症的影像学:图像综述
Clin Neuroradiol. 2021 Mar;31(1):61-71. doi: 10.1007/s00062-020-00929-8. Epub 2020 Jul 16.
10
Characterization of blood-brain barrier integrity in a B-cell-dependent mouse model of multiple sclerosis.在多发性硬化症的B细胞依赖性小鼠模型中血脑屏障完整性的特征分析
Histochem Cell Biol. 2019 Jun;151(6):489-499. doi: 10.1007/s00418-019-01768-6. Epub 2019 Jan 21.